American Journal of Infection Control

The worldwide emergence of carbapenem-resistance is a growing concern, particularly among Pseudomonas aeruginosa isolates.1 This microorganism display a large arsenal of resistance mechanisms which can contribute for the carbapenem-resistance

Severe acute respiratory syndrome coronavirus 2 is an emerging pathogen that is spreading worldwide. It is primarily transmitted by respiratory droplets and by direct and indirect contact; however, airborne transmission can also occur in the context

In the context of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the pandemic of the coronavirus disease-2019 (COVID-19) in the United States (US), the Centers for Disease Control and Prevention (CDC) has recommended the

SARS-CoV-2, the virus that causes COVID-19, is primarily spread person-to-person via contact with infected respiratory droplets.1 It is estimated that an individual may be infectious prior to becoming symptomatic.2 Areas with crowded work spaces and

The novel coronavirus severe acute respiratory syndrome coronavirus 2-infected pneumonia was first identified in Wuhan City and referred to as the COVID-19 by the World Health Organization (WHO). It is causing a global pandemic currently. In order to

Environmental surfaces in the hospital have long been identified as a reservoir for pathogens such as methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and Clostridiodes difficile. Although previous studies suggested a

SARS-CoV-2 has spread rapidly affecting over 10.4 million global citizens and the easy of spread has been demonstrated by the high burden across the globe.1 Two characteristics of the virus that offers an understanding of the effectiveness for

One of primary goals of infection control programs during the coronavirus disease 2019 (COVID-19) pandemic is to minimize the risk for acquisition of infection by healthcare personnel. Factors such as inadequate personal protective equipment, work

Coronavirus outbreak (COVID-19) has spread rapidly around the world and has been considered as a pandemic by WHO in March 2020.1 The transmission occurs from person to person through droplets when an infected person coughs or sneezes, or through

Primary prevention of Clostridioides (Clostridium) difficile infections (CDI) remains a leading clinical challenge due to the persistence of C. difficile spores, ease of transmission in health care settings and the prevalence of common risk factors